Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history.

Health and Human Services Secretary Robert F. Kennedy Jr.

FDA panel recommends loosening restrictions on peptides, despite scientists’ concerns

 What to know

A Food and Drug Administration advisory panel is voting on whether to make seven peptides more accessible, despite FDA scientists' concerns about safety and efficacy. The panel includes members that ethics and medical experts have accused of having conflicts of interests. The FDA will ultimately decide whether to approve, but the panel's recommendations could influence the decision. Peptide proponents argue that allowing compounding pharmacies to produce the chemicals will allow safer access, while critics cite insufficient evidence of efficacy or safety.

Summary is AI-generated, newsroom-reviewed.

Join the conversation

Have a question? Ask the Post AI to learn more